These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 11365909

  • 21. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW.
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [Abstract] [Full Text] [Related]

  • 22. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract] [Full Text] [Related]

  • 23. The growing debate over FDA reform. Food and Drug Administration.
    Link D.
    GMHC Treat Issues; 1996 Jan; 10(1):1-5. PubMed ID: 11363372
    [Abstract] [Full Text] [Related]

  • 24. Advertising for AIDS drugs: it's everywhere lately, but is it helpful?
    Mirken B.
    BETA; 1998 Jul; ():18-22. PubMed ID: 11365555
    [Abstract] [Full Text] [Related]

  • 25. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory.
    Blackwell AE, Beck JM, Dechert, L.L.P, Philadelphia, USA.
    Food Drug Law J; 2003 Jul; 58(3):439-62. PubMed ID: 14626985
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. FDA questions San Francisco HIV/AIDS drug advertisements.
    AIDS Policy Law; 2001 May 11; 16(9):1, 6. PubMed ID: 11668819
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FDA issues import alert against unapproved mail-order drugs.
    Am J Hosp Pharm; 1992 May 11; 49(5):1024. PubMed ID: 1595726
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.
    Baker R.
    BETA; 1998 Jul 11; ():8-9. PubMed ID: 11365570
    [Abstract] [Full Text] [Related]

  • 36. Drug promotion.
    Stryer DB, Bero LA.
    N Engl J Med; 1995 Apr 13; 332(15):1032; author reply 1033. PubMed ID: 7885416
    [No Abstract] [Full Text] [Related]

  • 37. Drug Regulation Reform Act of 1978.
    Greenberg RB.
    Am J Hosp Pharm; 1978 Jun 13; 35(6):729-32. PubMed ID: 665689
    [Abstract] [Full Text] [Related]

  • 38. FDA tightens rules on advertising.
    Josefson D.
    BMJ; 1997 Aug 23; 315(7106):447. PubMed ID: 9284658
    [No Abstract] [Full Text] [Related]

  • 39. The suboptimal legibility of prescribing information in pharmaceutical advertisements.
    Lohiya S, Lohiya S.
    J Am Board Fam Med; 2007 Aug 23; 20(3):314-5. PubMed ID: 17478666
    [No Abstract] [Full Text] [Related]

  • 40. Manufacturers' promotion of off-label drug use: implications for drug safety.
    Zieve A, Carome MA.
    Expert Opin Drug Saf; 2016 Sep 23; 15(9):1149-51. PubMed ID: 27145440
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.